相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutations associated with epileptic encephalopathy modify EAAT2 anion channel function
Peter Kovermann et al.
EPILEPSIA (2022)
Loss of glutamate transporter eaat2a leads to aberrant neuronal excitability, recurrent epileptic seizures, and basal hypoactivity
Adriana L. Hotz et al.
GLIA (2022)
SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population
Ali Mir et al.
HUMAN GENETICS (2022)
Induction of Parkinsonian-Like Changes via Targeted Downregulation of Astrocytic Glutamate Transporter GLT-1 in the Striatum
Chao Ren et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Polymorphism of rs12294045 in EAAT2 gene is potentially associated with schizophrenia in Chinese Han population
Lina Wang et al.
BMC PSYCHIATRY (2022)
Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
Martina Montanari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Treatment effects of the combination of ceftriaxone and valproic acid on neuronal and behavioural functions in a rat model of epilepsy
Hsin-Hua Li et al.
EXPERIMENTAL PHYSIOLOGY (2021)
GLT1 gene delivery based on bone marrow-derived cells ameliorates motor function and survival in a mouse model of ALS
Natsuko Ohashi et al.
SCIENTIFIC REPORTS (2021)
Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra
Yunlong Zhang et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Ceftriaxone pretreatment confers neuroprotection in rats with acute glaucoma and reduces the score of seizures induced by pentylenotetrazole in mice
Helene A. Fachim et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2020)
Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis
Lifu Sheng et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Hsp90 inhibitor HSP990 in very low dose upregulates EAAT2 and exerts potent antiepileptic activity
Longze Sha et al.
THERANOSTICS (2020)
Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status
Roberta Celli et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics
Edward Pajarillo et al.
NEUROPHARMACOLOGY (2019)
Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism
Andrew B. Stergachis et al.
ANNALS OF NEUROLOGY (2019)
Glutamate Transport and Preterm Brain Injury
Silvia Pregnolato et al.
FRONTIERS IN PHYSIOLOGY (2019)
Regulation of Synaptosomal GLT-1 and GLAST during Epileptogenesis
Allison R. Peterson et al.
NEUROSCIENCE (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Epigenetic Regulation of Excitatory Amino Acid Transporter 2 in Neurological Disorders
Mohammad Afaque Alam et al.
FRONTIERS IN PHARMACOLOGY (2019)
Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-κB Pathways
Pratap Karki et al.
MOLECULAR NEUROBIOLOGY (2018)
Biallelic Mutations in SLC1A2; an Additional Mode of Inheritance for SLC1A2-Related Epilepsy
Matias Wagner et al.
NEUROPEDIATRICS (2018)
Spinal cord-specific deletion of the glutamate transporter GLT1 causes motor neuron death in mice
Kaori Sugiyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Loss of cerebellar glutamate transporters EAAT4 and GLAST differentially affects the spontaneous firing pattern and survival of Purkinje cells
Emma M Perkins et al.
HUMAN MOLECULAR GENETICS (2018)
Neurotransmitters in the mediation of cerebral ischemic injury
Diana Mayor et al.
NEUROPHARMACOLOGY (2018)
Valproic acid attenuates manganese-induced reduction in expression of GLT-1 and GLAST with concomitant changes in murine dopaminergic neurotoxicity
James Johnson et al.
NEUROTOXICOLOGY (2018)
Glutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies
Paula Garcia-Esparcia et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study
Anthoula C. Tsolaki et al.
NEURODEGENERATIVE DISEASES (2018)
The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex
Binkai Chi et al.
NUCLEIC ACIDS RESEARCH (2018)
Inhibition of p38 MAPK Signaling Regulates the Expression of EAAT2 in the Brains of Epileptic Rats
Zhang Yang et al.
FRONTIERS IN NEUROLOGY (2018)
Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
Georgia M. Parkin et al.
WORLD JOURNAL OF PSYCHIATRY (2018)
Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy
Longze Sha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Mechanisms of Excessive Extracellular Glutamate Accumulation in Temporal Lobe Epilepsy
Jan Albrecht et al.
NEUROCHEMICAL RESEARCH (2017)
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
Ingrid E. Scheffer et al.
EPILEPSIA (2017)
The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients
Davide Mei et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model
Yunlong Zhang et al.
CELL DEATH & DISEASE (2017)
The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders
Sinead M. O'Donovan et al.
NPJ SCHIZOPHRENIA (2017)
De Novo Mutations in YWHAG Cause Early-Onset Epilepsy
Ilaria Guella et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion
Nicholas M. Allen et al.
EPILEPSIA (2016)
Lessons learned from gene identification studies in Mendelian epilepsy disorders
Katia Hardies et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies
Candace T. Myers et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Regulation of astrocyte glutamate transporter-1 (GLTI) and aquaporin-4 (AQP4) expression in a model of epilepsy
Jacqueline A. Hubbard et al.
EXPERIMENTAL NEUROLOGY (2016)
Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy
Katherine L. Helbig et al.
GENETICS IN MEDICINE (2016)
Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease
Kou Takahashi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Taming Glutamate Excitotoxicity: Strategic Pathway Modulation for Neuroprotection
Ming Jia et al.
CNS DRUGS (2015)
Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease
Marianne Amalric
CURRENT OPINION IN PHARMACOLOGY (2015)
Targeting glutamatergic synapses in Parkinson's disease
Fabrizio Gardoni et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease
Kou Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Conditional Deletion of the Glutamate Transporter GLT-1 Reveals That Astrocytic GLT-1 Protects against Fatal Epilepsy While Neuronal GLT-1 Contributes Significantly to Glutamate Uptake into Synaptosomes
Geraldine T. Petr et al.
JOURNAL OF NEUROSCIENCE (2015)
Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: Putative mechanism for manganese-induced neurotoxicity
Pratap Karki et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Astroglial Glutamate Transporter Deficiency Increases Synaptic Excitability and Leads to Pathological Repetitive Behaviors in Mice
Tomomi Aida et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Glutamatergic Mechanisms Associated with Seizures and Epilepsy
Melissa Barker-Haliski et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia
S. M. O'Donovan et al.
TRANSLATIONAL PSYCHIATRY (2015)
De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
Silke Appenzeller et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia
S. Poletti et al.
EUROPEAN PSYCHIATRY (2014)
Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy
D. Young et al.
GENE THERAPY (2014)
Sumoylation of the Astroglial Glutamate Transporter EAAT2 Governs Its Intracellular Compartmentalization
E. Foran et al.
GLIA (2014)
Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection
Qiongman Kong et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Differential regulation of the glutamate transporters GLT-1 and GLAST by GSK3β
Esperanza Jimenez et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
SLC1 glutamate transporters
Christof Grewer et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)
Exploring effects of EAAT polymorphisms on cognitive functions in schizophrenia
Marco Spangaro et al.
PHARMACOGENOMICS (2014)
Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain
Grzegorz Sulkowski et al.
PLOS ONE (2014)
Animal model of autism induced by prenatal exposure to valproate: Altered glutamate metabolism in the hippocampus
Roberta Bristot Silvestrin et al.
BRAIN RESEARCH (2013)
Glutamate, Glutamate Receptors, and Downstream Signaling Pathways
Stacey S. Willard et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
De novo mutations in epileptic encephalopathies
Andrew S. Allen et al.
NATURE (2013)
Glutamate transporter expression and function in a striatal neuronal model of Huntington's disease
Geraldine T. Petr et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
MECHANISMS OF GLUTAMATE TRANSPORT
Robert J. Vandenberg et al.
PHYSIOLOGICAL REVIEWS (2013)
Manganese Neurotoxicity: a Focus on Glutamate Transporters
Pratap Karki et al.
ANNALS OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2013)
Hippocampal glutamate transporter 1 (GLT-1) complex levels are paralleling memory training in the Multiple T-Maze in C57BL/6J mice
Seok Heo et al.
BRAIN STRUCTURE & FUNCTION (2012)
Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases
Chien-Liang Glenn Lin et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Astrocytic regulation of glutamate homeostasis in epilepsy
Douglas A. Coulter et al.
GLIA (2012)
Relationship between increase in astrocytic GLT-1 glutamate transport and late-LTP
Juan D. Pita-Almenar et al.
LEARNING & MEMORY (2012)
Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus
Qiongman Kong et al.
NEUROBIOLOGY OF DISEASE (2012)
Cognitive dysfunction and glutamate reuptake: Effect of EAAT2 polymorphism in schizophrenia
Marco Spangaro et al.
NEUROSCIENCE LETTERS (2012)
GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer's Disease Animal Model
Paramita Mookherjee et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Role of Excitatory Amino Acid Transporter-2 (EAAT2) and Glutamate in Neurodegeneration: Opportunities for Developing Novel Therapeutics
Keetae Kim et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease
Heather A. Scott et al.
NEUROBIOLOGY OF AGING (2011)
Targeted Over-Expression of Glutamate Transporter 1 (GLT-1) Reduces Ischemic Brain Injury in a Rat Model of Stroke
Brandon K. Harvey et al.
PLOS ONE (2011)
Aberrant Detergent-Insoluble Excitatory Amino Acid Transporter 2 Accumulates in Alzheimer Disease
Randall L. Woltjer et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Blockade of Astrocytic Glutamate Uptake in Rats Induces Signs of Anhedonia and Impaired Spatial Memory
Anita J. Bechtholt-Gompf et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Stephen F. Traynelis et al.
PHARMACOLOGICAL REVIEWS (2010)
Cognitive Decline in Alzheimer's Disease Is Associated with Selective Changes in Calcineurin/NFAT Signaling
Hafiz Mohmmad Abdul et al.
JOURNAL OF NEUROSCIENCE (2009)
Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism
S. Xu et al.
CYTOGENETIC AND GENOME RESEARCH (2008)
Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1
Elena Fumagalli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes
Seok-Geun Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Downregulation of Glial Glutamate Transporters after Dopamine Denervation in the Striatum of 6-Hydroxydopamine-Lesioned Rats
E. K. Y. Chung et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
The Yin and Yang of YY1 in the nervous system
Ye He et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression:: Involvement of Ying-Yang 1
Gisela Aguirre et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia
M. L. Weller et al.
NEUROSCIENCE (2008)
Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia
Deborah Bauer et al.
SCHIZOPHRENIA RESEARCH (2008)
Transporters for L-glutamate: An update on their molecular pharmacology and pathological involvement
P. M. Beart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders
T. L. Lauriat et al.
MOLECULAR PSYCHIATRY (2007)
A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis
Stuart L. Gibb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention
Amanda L. Sheldon et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Paradoxical Upregulation of Glutamatergic presynaptic boutons during mild cognitive impairment
Karen F. S. Bell et al.
JOURNAL OF NEUROSCIENCE (2007)
Anti-glutamatergic effect of riluzole: Comparison with valproic
J.-E. Kim et al.
NEUROSCIENCE (2007)
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
Peter Szatmari et al.
NATURE GENETICS (2007)
Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation
Kon Chu et al.
STROKE (2007)
Glutamate transporters GLAST and EAAT4 regulate postischemic Purkinje cell death: An in vivo study using a cardiac arrest model in mice lacking GLAST or EAAT4
Akihide Yamashita et al.
NEUROSCIENCE RESEARCH (2006)
Caspase-3 cleaves and inactivates the glutamate transporter EAAT2
William Boston-Howes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Extracellular metabolites in the cortex and hippocampus of epileptic patients
I Cavus et al.
ANNALS OF NEUROLOGY (2005)
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
JD Rothstein et al.
NATURE (2005)
Electrogenic glutamate transporters in the CNS: Molecular mechanism, pre-steady-state kinetics, and their impact on synaptic signaling
C Grewer et al.
JOURNAL OF MEMBRANE BIOLOGY (2005)
l-Dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
HK Holmer et al.
NEUROSCIENCE (2005)
Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease
PA Löschmann et al.
EXPERIMENTAL NEUROLOGY (2004)
Glutamate transporter expression and function in human glial progenitors
NJ Maragakis et al.
GLIA (2004)
Autism spectrum disorder in fragile X syndrome: Communication, social interaction, and specific behaviors
WE Kaufmann et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs
Y Shigeri et al.
BRAIN RESEARCH REVIEWS (2004)
Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)
SJ Wang et al.
NEUROSCIENCE (2004)
Identification of motifs involved in endoplasmic reticulum retention-forward trafficking of the GLT-1 subtype of glutamate transporter
A Kalandadze et al.
JOURNAL OF NEUROSCIENCE (2004)
Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress
M Tortarolo et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice
H Guo et al.
HUMAN MOLECULAR GENETICS (2003)
Excitatory amino acid transporters: keeping up with glutamate
SG Amara et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain
WZ Chen et al.
JOURNAL OF NEUROSCIENCE (2002)
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
DS Howland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels
C Bendotti et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain:: the role of Aβ1-42
CM Lauderback et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain
VLR Rao et al.
JOURNAL OF NEUROSCIENCE (2001)
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease
C Ferrarese et al.
NEUROLOGICAL SCIENCES (2001)
Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity
D Trotti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
